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Abstract
Polycystic Ovarian Syndrome (PCOS) is inflammatory disease characterized by hyperandrogen-
emia, hyperthecosis and chronic anovulation. Honey bee venom (HBV) contains a variety of bio-
logically active components having various pharmaceutical properties. This study was designed 
to detect the possibility of HBV application as an anti-inflammatory therapeutic agent. To induce 
PCOS, 2mg/100gr B.W Estradiol Valerate (EV) was subcutaneously injected to induce PCOS in 
mature Wistar rats then ovaries and serum from three groups of EV-induced PCOS, HBV-treat-
ment and normal intact animals were collected for histological comparison and blood sugar test. 
As a result, a significant increase in ovarian weight was observed in experimental group rather 
than controls. Furthermore, in HBV-treated group a significant decrease was observed in ovary 
weight comparing with experimental group (P<0.01). The results obtained from Chemo Lumine-
sance Immuno Assay (CLIA) declared that testosterone and Estradiol levels in experimental 
group significantly increased (P<0.001). These hormones were decreased in animals treated with 
HBV.  Blood sugar level showed reduction in HBV-treated rats. Thickness of theca layer, number 
and diameter of cysts significantly decrease in HBV group comparing to PCOS group. Moreover, 
corpus luteum, as a sign of ovulation, was observed in HBV-treated ovaries. In conclusion our 
results suggest that beneficial effect of HBV against PCOS may be mediated by the inhibitory 
effect of HBV on TNF-α level.
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1. Introduction
Polycystic Ovarian Syndrome (PCOS) is an inflammatory disease characterized by hyper an-
drogenemia, hyperthecosis, hyperglycemia and chronic anovulation(1-6). Honey bee venom 
(HBV) contains a variety of biologically active components like peptides (Melittin and Apamin), 
enzymes and biologically active amines (histamine, epinephrine. It has shown that HBV has an-
algesic, anti-cancer and anti-inflammatory activity. Melittin, the major active ingredient of BV, 
has been reported to induce apoptosis and to possess anti-proliferation effects (7-9). TNF-α is 
a key inflammatory stimulus which plays a main role in regulating normal activity of ovary in 
follicular growth and luteal stages. It’s over expression in adipose tissue leads to obesity and 
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insulin-resistance in humans and rodents. This factor by stimulating mitotic activity in undif-
ferentiated theca cells and increasing steroidogenic cells causes PCOS (10-13). Whereas the anti-
inflammatory and anticancer effects of HBV were proved, we examined sugar levels in rats with 
PCOS before and after treatment via HBV. We also measured plasma testosterone and theca layer 
thickness, the commonly used index of PCOS (1). We hypothesized that HBV can modulate hy-
perglycemia in bee venom-treated rat with PCOS in response to androgenemia, compared with 
age-matched controls.
2. Materials and Methods
Experiments were performed on Female Wistar rats (170±20g). Before and during the experi-
ment they were housed in special cages with a standard space and under controlled cycle of light 
and darkness (lights on from 06:00 to 20:00), humidity 55±15% and temperature range of 20-24˚c 
and free access to water and commercial food (Behparvar Com., Iran). Induction of PCOS was 
administered using 1mg/100gr B.W intramuscular injection of EV. After verifying the induction 
of PCOS, experimental group was divided into two groups: PCOS group and PCOS+BV group. 
PCOS+BV received 0.5 mg/kg BV sc for 14 days, continuously (7). PCOS group in this period of 
time received physiological saline solution. At around 09:00 am, trunk blood was collected and 
the serums were separated using 4000 RPM centrifuge for 10 min. The ovaries were separated 
from the twisted oviduct tubes and were placed in bouin fixative for histological analysis; fixed 
samples were kept in alcohol solutions of 20 to 100% for a period of 45 min for dehydration and 
afterwards in alcohol/xylen (50:50) and xylen (3 times) for clearing and blocked in paraffin. The 
samples were sliced in 7 micron thickness using a microtome and the sections were placed on 
slides previously coated with gelatin and then stained with hematoxylin-eosin for histological 
observation. Serological analysis was performed to measure sugar level and hormone altera-
tions. Testosterone and estradiol detected by Chemo Luminesance Immuno Assay (CLIA). In or-
der to detect suger, glucose kit (GOD_PAP 90014) was used. The one-way ANOVA and INSTAT 
software were used to determine the statistical significance of differences between the values 
for the experimental and control groups. Data are expressed as means ± standard errors (S.E.M) 
and the results are taken from at least three independent experiments performed in triplicate. 
P-values of 0.05 or less were considered statistically significant.
3. Results
The ovaries were also precisely weighted and a significant increase was observed in experimen-
tal group rather than controls. Furthermore, in bee venom-treated group a significant decrease 
was observed in ovary weight comparing with experimental group (P<0.01). The results obtained 
from CLIA declared that testosterone and Estradiol levels in experimental group significantly 
increased (P<0.001). These hormones were decreased in animals treated with bee venom, and 
comparing with animals in control group they were regulated. Reduction observed in testos-
terone and Estradiol levels was significant with P<0.05. These data including raise in androgens 
showed that induce of syndrome was absolutely successful. What more is bee venom managed 
to reduce Estradiol and testosterone.(Table1) sugar level fundamentally adjusts its production, 
which in this study, PCOS induction by means of Estradiol volerate led to a significant raise in 
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sugar level (P<0.01), and its reduction in rats treated with honey bee venom was outstanding 
(P<0.05).  (Diagram1).
 
Diagram 1. Different sugar level in control and polycystic rats (n=10). In polycystic group, a significant in-
crease was observed in sugar level. ***P< 0.001, PCOS vs. control, HBV vs. PCOS group.
Cont SD SEM PCOS SD SEM PCOS+BV SD SEM con vs pcos
con vs 
pc+bv
pcos vs 
pc+bv
Estradiol  
(pg/ml) 14.5 1.958 0.6191 54.778 8.599 2.866 21.889 4.485 1.495 *** P<0.001 *   P<0.05 *** P<0.001
Testosteron 
(ng/dl) 62.5 9.925 3.138 345.9 112.99 35.73 115.9 39.145 12.379 *** P<0.001  ns  P>0.05 *** P<0.001
Ovarian 
weight (mg) 13 3.232 1.022 20.5 4.577 1.447 15 4.714 1.491 **  P<0.01 ns  P>0.05 *   P<0.05
Theca layer 
-late antral 
follicles (mi-
crometer)
99.8 11.144 3.524 157.2 44.183 13.972 110.7 23.281 7.362
*** 
P<0.001
ns  
P>0.05
**  
P<0.01
Table 1.  Bee venom treatment effects in polycystic ovarian syndrome (PCOS). Baseline parameters of polycys-
tic ovarian syndrome (PCOS) rats (n=10) and control (n=10) and bee venom –treated rats (n=10).
In order to determine follicular development, follicles were classified based on morphology and 
diameter into 6 groups consisting of: primordial, primary and preantral (<600µm), antral (600-
1000µm), cystic follicles, and corpus luteum. Decrease in the number of primary follicles, antral 
follicles and corpus luteums was significant with P<0.001, in primordial follicles with P<0.01, and 
in preantral follicles with P<0.05. In PCOS ovaries, some large cystic follicles with thick theca 
layer were observed. In this group, no corpus luteum as a sign of ovulation was seen.
In rats treated with honey bee venom, the number of primordial and preantral follicles and cor-
pus luteums increased, whereas, the number of cysts and thickness of theca layer in antral fol-
licles decreased, which these changes were significant in comparison with sham group. Also, 
some corpus luteums were observed in this group which was considered as a sign of relative 
improvement in PCOS ovaries. (Diagram 2 and 3).
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Diagram 2. Different follicular groups in control and polycystic ovaries (n=10). In ovaries of polycystic group, 
a significant increase and decrease was observed in number of cysts and number of corpus luteums respec-
tively. ***P< 0.001, **P< 0.01, *P< 0.05. (PMF, Pre Mordial Follicle; PF, Primary Follicle; PAF, Preantral Follicle, 
AF, Antral Follicle; CF, Cystic Follicle; CL, Corpus Luteum.)
Diagram 3. Different follicular types in ovaries of polycystic and bee-venom treated polycystic group. In 
polycystic ovaries treated with honey bee venom (n=10), a significant increase was observed in all follicular 
clusters (except primordial follicles) rather than polycystic group. The primordial follicles were not signifi-
cantly increased. Moreover, a significant decrease was seen in the number of ovarian cysts. ***P<0.001, **P< 
0.01. (PMF, Pre Mordial Follicle; PF, Primary Follicle; PAF, Preantral Follicle, AF, Antral Follicle; CF, Cystic Follicle; 
CL, Corpus Luteum.)
4. Summary and conclusion
Insulin sensitivity and hyperglycemia is directly related to androgen levels (14). These findings 
suggest that hyperandrogenism play a role in the development of insulin resistance and hy-
perandrogenism in PCOS. It is considered metformin as a treatment for PCOS which has been 
shown to inhibit the NF-ҡB activation and also reduce sugar level in PCOS woman (15). Then we 
can also name honey bee venom as a similar factor decreasing sugar level. Histological changes 
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observed in ovary after bee venom treatment, can also be considered as a confirmation for this 
syndrome progress. Our results confirm that Bee venom caused a decrease in follicular theca 
layer in PCOS rats, which is actually because of increased lipolysis and decreased hypertrophy 
of this layer. Due to this decrease, the androgens and steroids produced by this layer also de-
crease and consequently the total levels of serumic estrogen and androgens reduce by honey 
bee venom. In this regard we have demonstrated that bee venom injection produces a significant 
anti-hyperglycemia effect in PCOS Wistar rats.
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